Pramipexol shortage — CO supply status & alternatives

Pramipexol

—

🇦🇺 AUST R 214445

In supply · Australia

In supply · 🇦🇺 Australia · short in🌐 CO🇳🇱 NL🇵🇹 PT

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Marketing-authorisation holders
Active ingredient (INN)	Pramipexol
Therapeutic category	Auto-created by CBG-MEB (Netherlands) scraper
Controlled substance	No

Registrations on file	29

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Other markets

🇬🇧 GB

£2.56

Drug Tariff

🇺🇸 US

US$0.05

Acquisition

🇪🇸 ES

€22.00

Retail price

🇫🇷 FR

€18.88

Retail price

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

1 API manufacturer

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Very high concentration risk

Piramal Pharma LTD

Manufacturing countries: India · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders29 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
PEXOLE pramipexole dihydrochloride	1 mg	—	🇦🇺 AU	—	Active
PAMEX pramipexole dihydrochloride	1 mg	—	🇦🇺 AU	—	Active
PEXOLE pramipexole dihydrochloride	0.25 mg	—	🇦🇺 AU	—	Active
ZIPEXOLE pramipexole dihydrochloride	0.125 mg	—	🇦🇺 AU	—	Active
ZIPEXOLE pramipexole dihydrochloride	0.25 mg	—	🇦🇺 AU	—	Active
PAMEX pramipexole dihydrochloride	0.25 mg	—	🇦🇺 AU	—	Active
PRAMIPEXOLE GPPL pramipexole dihydrochloride	0.5 mg	—	🇦🇺 AU	—	Active
PEXOLE pramipexole dihydrochloride	1.5 mg	—	🇦🇺 AU	—	Active
PRAMIPEXOLE GxP pramipexole dihydrochloride	1 mg	—	🇦🇺 AU	—	Active
ZIPEXOLE pramipexole dihydrochloride	1.5 mg	—	🇦🇺 AU	—	Active
PRAMIPEXOLE GxP pramipexole dihydrochloride	0.5 mg	—	🇦🇺 AU	—	Active
PEXOLE XR pramipexole dihydrochloride monohydrate	0.75 mg	—	🇦🇺 AU	—	Active
PRAMIPEX XR pramipexole dihydrochloride monohydrate	1.5 mg	—	🇦🇺 AU	—	Active
PRAMI XR pramipexole dihydrochloride monohydrate	2.25 mg	—	🇦🇺 AU	—	Active
SIFROL pramipexole dihydrochloride monohydrate	250 microgram	—	🇦🇺 AU	Boehringer Ingelheim Pty Ltd	Active

+14 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.